Clinical Research Directory
Browse clinical research sites, groups, and studies.
RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial
Sponsor: European Society for Blood and Marrow Transplantation
Summary
After exiting the RACE trial (NCT02099747) patients will be invited to participate in this long term follow-up study
Official title: Long-term Follow-up of Patients Participating in RACE: the Prospective Randomized Multicenter Study Comparing Horse Antithymocyte Globuline (hATG) + Cyclosporine A (CsA) With or Without Eltrombopag as Front-line Therapy for Severe Aplastic Anemia Patients
Key Details
Gender
Not specified
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
197
Start Date
2021-10
Completion Date
2034-12
Last Updated
2021-09-27
Healthy Volunteers
Not specified
Conditions
Interventions
ATGAM plus CsA with or without Eltrombopag
Standard treatment with or without Eltrombopag
Locations (1)
Hospital St. Louis
Paris, France